Selank 10mg

THIS PRODUCT IS INTEDED AS A RESEARCH CHEMICAL ONLY.
This designation allows the use of research chemicals strictly in vitro for testing and laboratory experimentation only. All products information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professional. This product is not a drug, food or cosmetic and may not be misbranded, misused or mislabled as a drug food or cosmetic.

Product Summary

Selank 10mg: a synthetic heptapeptide derived from tuftsin, studied extensively for anxiolytic and nootropic properties in preclinical research applications.

Key Features

• High-purity synthetic heptapeptide (>97% purity)
  
• Enhanced metabolic stability with extended Pro-Gly-Pro sequence
  
• Extensively researched anxiolytic and cognitive enhancement properties
  
• Lyophilized powder format for optimal stability
  
• Suitable for advanced research applications
  

What Is Selank 10mg?

In the world of synthetic peptides, few compounds command as much attention as Selank. This isn't mere scientific fashion—there's substance here.

Selank emerged from Russian laboratories in the 1980s, when researchers at the Institute of Molecular Genetics decided that nature's tuftsin needed improvement. They weren't wrong. The original tetrapeptide, while biologically active, degraded too quickly to be practically useful. So they built something better.

The result? A seven amino acid sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro. Simple enough to write on a napkin, complex enough to influence multiple neurotransmitter systems. That additional Pro-Gly-Pro tail isn't decorative—it's the difference between a peptide that lasts minutes and one that can actually do its job.

What sets Selank apart from pharmaceutical anxiety treatments is its mechanism. Rather than bulldozing through GABA receptors like benzodiazepines do, Selank appears to work more like a skilled negotiator—enhancing natural processes without overwhelming them. The research suggests it modulates GABAergic pathways while also influencing serotonin, dopamine, and enkephalin signaling. That's a lot of moving parts for seven amino acids.

Selank 10mg Overview

Here's what makes peptide researchers lose sleep over Selank: it appears to influence gene expression.

Not just any genes, mind you. We're talking about 52 of the 84 genes associated with GABA signaling pathways. That's the kind of comprehensive neurochemical influence that pharmaceutical companies spend billions trying to achieve with small molecule drugs.

The mechanism is elegant. Instead of jamming itself into GABA-A receptors like a square peg, Selank seems to work allosterically—changing the receptor's shape to make it more receptive to natural GABA. Think of it as tuning a radio to pick up signals more clearly rather than cranking up the volume.

This explains something puzzling about early Selank studies. Researchers expected sedation—after all, most things that enhance GABA activity make you sleepy. Instead, they found alertness combined with reduced anxiety. The compound was doing something fundamentally different.

Then there's the BDNF story. Brain-derived neurotrophic factor sounds like marketing copy, but it's actually crucial for neural plasticity. Research indicates Selank can rapidly boost BDNF expression in hippocampal regions. Translation: it might help brain cells grow and connect more effectively.

Chemical Makeup

Molecular Formula: C33H57N11O9
Molecular Weight: 751.87 g/mol
Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP)
CAS Number: 129954-34-3
Synonyms: TP-7, Selanc

The chemistry here tells of optimization.

Take the N-terminal sequence—it mirrors tuftsin exactly. But that C-terminal extension? Pure innovation. Three amino acids that transform a fragile natural peptide into something stable enough for research applications.

In plasma, unmodified tuftsin survives barely long enough to measure. Selank persists for 7-10 minutes—not long by pharmaceutical standards, but revolutionary compared to its predecessor. Those three extra amino acids earn their keep by creating steric hindrance around peptidase cleavage sites.

Selank Research

GABAergic System Modulation

The GABA story gets interesting when you examine the genetics.

Contemporary gene expression analysis reveals something remarkable: Selank administration affects transcription of multiple genes involved in GABA signaling. We're not talking about subtle tweaks here—entire receptor subunits, transporters, and ion channels show altered expression patterns.

But here's where it gets clever. While diazepam and its cousins work by direct receptor occupation, Selank appears to function as a positive allosteric modulator. It doesn't compete with natural GABA for binding sites—instead, it changes the receptor's shape to increase GABA's binding affinity.

This distinction matters. Direct agonists often produce tolerance, dependence, and cognitive impairment. Allosteric modulators tend to be more forgiving. Research comparing Selank to diazepam in chronic stress models showed comparable anxiolytic efficacy, but with combination therapy demonstrating enhanced benefits. The compounds were working together, not against each other.

Cognitive Enhancement and Memory

Memory research with Selank produces results that pharmaceutical companies would kill for.

Studies using conditioned avoidance response training showed improved learning efficiency—fewer errors, better solution accuracy. The kind of cognitive enhancement that doesn't come with stimulant side effects or midnight anxiety attacks.

The mechanism appears to involve hippocampal gene expression changes. Thirty-six genes showed altered transcription patterns, many encoding proteins essential for memory formation. This isn't just behavioral change—it's molecular reprogramming of learning circuits.

Perhaps most intriguingly, research on alcohol-induced cognitive impairment found that Selank helped preserve brain function. The peptide seemed to protect BDNF levels even under neurotoxic conditions. If confirmed, this suggests neuroprotective properties beyond simple cognitive enhancement.

Neurotransmitter System Interactions

Selank's influence extends far beyond GABA.

Serotonin metabolism in brainstem regions shows enhancement, particularly under conditions of serotonergic impairment. This mechanism could explain mood-regulating effects observed in various research models. The compound isn't just reducing anxiety—it's potentially addressing underlying neurotransmitter imbalances.

Dopamine receptor gene expression also changes with Selank treatment. D5 receptor transcription activation at extended time points suggests involvement in long-term potentiation processes. This could explain why cognitive benefits sometimes persist beyond the compound's immediate presence.

Then there's the enkephalin connection. Research indicates Selank may inhibit enzymes that degrade these endogenous opioid peptides. By preserving natural enkephalins, the compound potentially modulates stress response and pain perception without direct opioid receptor activation.

Immunomodulatory Properties

The immune system effects weren't expected—they were discovered by accident.

Clinical studies in anxiety populations revealed that Selank altered interleukin-6 levels and T-helper cell cytokine ratios. This wasn't supposed to happen with an anxiolytic peptide, but there it was in the data.

Gene expression analysis confirmed the finding. Selank influences transcription of genes encoding chemokines, cytokines, and their receptors. The compound wasn't just affecting the nervous system—it was modulating immune function as well.

This suggests applications beyond anxiety management, though much work remains to understand the clinical implications.

Safety Considerations

Selank's safety profile looks reassuring in preclinical work, but research demands vigilance.

Documented effects remain mild: occasional nasal irritation with intranasal use, rare headaches, isolated reports of drowsiness or mood changes. These typically resolve with dosage adjustment or protocol modification.

Drug interactions require careful consideration. While specific contraindications remain incompletely characterized, combining Selank with other neuroactive compounds demands caution. GABAergic, serotonergic, or dopaminergic medications could produce unexpected interactions.

Individuals with autoimmune conditions should approach use carefully. The compound's immunomodulatory properties, while potentially beneficial, could theoretically exacerbate existing immune dysfunction.

Research Disclaimer: This product serves research purposes exclusively and lacks approval for human consumption. While studies suggest therapeutic potential, comprehensive clinical validation continues. Researchers must consult appropriate safety guidelines and institutional protocols before use. Regulatory authorities haven't evaluated these statements, and this product isn't intended to diagnose, treat, cure, or prevent any condition.

Quality Assurance: Each batch undergoes rigorous quality control testing ensuring >97% purity and research standard compliance. Certificates of analysis are available upon request.

Research references derive from current scientific literature. Individual results vary, and this information serves educational purposes only. Qualified research professionals should be consulted before initiating any research protocol.